DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Haematological Malignancy · Melanoma · Thyroid Cancer, Papillary · Ovarian Neoplasms · Colorectal Neoplasms · Laryngeal Neoplasms · Carcinoma, Non-Small-Cell Lung · Glioma · Multiple Myeloma · Erdheim-Chester Disease · Thyroid Carcinoma, Anaplastic · Solid Tumour

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Belfast City Hospital, Belfast, United Kingdom
Contact: Study coordinator (Vicky Coyle, Prof) · V.Coyle@qub.ac.uk
Contact: Principal Investigator (Vicky Coyle, Prof)
University Hospital Birmingham, Birmingham, United Kingdom
Contact: Study coordinator (Gary Middleton, Prof) · G.Middleton@bham.ac.uk · 0121 371 3573
Contact: Principal Investigator (Gary Middleton, Prof)
Bristol Haematology and Oncology Centre, Bristol, United Kingdom
Contact: Study coordinator (Antony Ng, Dr) · Antony.Ng@uhbw.nhs.uk · 0117 342 8044
Contact: Principal Investigator (Antony Ng, Dr)
Addenbrooke's Hospital, Cambridge, United Kingdom
Contact: Study coordinator (Bristi Basu, Dr) · bb313@medschl.cam.ac.uk · 01223 596105
Contact: Principal Investigator (Bristi Basu, Dr)
Velindre Cancer Centre, Cardiff, United Kingdom
Contact: Study coordinator (Robert Jones, Dr) · Robert.Hugh.Jones@wales.nhs.uk · 02920 615888
Contact: Principal Investigator (Robert Jones, Dr)
Western General Hospital, Edinburgh, United Kingdom
Contact: Study coordinator (Stefan Symeonides, Dr)
Contact: Principal Investigator (Stefan Symeonides, Dr)
The Beatson Hospital, Glasgow, United Kingdom
Contact: Study coordinator (Patricia Roxburgh, Dr) · Patricia.Roxburgh@glasgow.ac.uk · 0141 301 7118
Contact: Principal Investigator (Patricia Roxburgh, Dr)
Leicester Royal Infirmary, Leicester, United Kingdom
Contact: Study coordinator (Olubukola Ayodele, Dr) · olubukola.ayodele@uhl-tr.nhs.uk · 0116 2587601
Contact: Principal Investigator (Olubukola Ayodele, Dr)
University College London Hospital, London, United Kingdom
Contact: Study coordinator (Martin Forster, Prof) · M.Forster@ucl.ac.uk · 020 3447 5085
Contact: Principal Investigator (Martin Forster, Prof)
Guy's Hospital, London, United Kingdom
Contact: Study coordinator (James Spicer, Dr) · james.spicer@kcl.ac.uk · 020 7188 4260
Contact: Principal Investigator (James Spicer, Dr)
The Christie Hospital, Manchester, United Kingdom
Contact: Study coordinator (Matthew Krebs, Dr) · matthew.krebs@nhs.net · 0161 918 7672
Contact: Principal Investigator (Matthew Krebs, Dr)
Clatterbridge Cancer Centre, Metropolitan Borough of Wirral, United Kingdom
Contact: Study coordinator (Dan Palmer, Dr) · daniel.palmer@liverpool.ac.uk · 0151 706 4172 / 0151 706 4177
Contact: Principal Investigator (Dan Palmer, Dr)
Freeman Hospital, Newcastle, United Kingdom
Contact: Study coordinator (Alastair Greystoke, Dr) · Greystoke@newcastle.ac.uk · 0191 2138476
Contact: Principal Investigator (Alastair Greystoke, Dr)
Churchill Hospital, Oxford, United Kingdom
Contact: Study coordinator (Sarah Pratap, Dr) · Sarah.Pratap@ouh.nhs.uk · 01865 235273
Contact: Principal Investigator (Sarah Pratap, Dr)
Weston Park Hospital, Sheffield, United Kingdom
Contact: Study coordinator (Sarah Danson, Dr) · s.danson@sheffield.ac.uk · 0114 226 5068
Contact: Principal Investigator (Sarah Danson, Dr)
Southampton General Hospital, Southampton, United Kingdom
Contact: Study coordinator (Juliet Gray, Prof) · Juliet.Gray@uhs.nhs.uk · 0238 120 6639
Contact: Principal Investigator (Juliet Gray, Prof)

Study leads

Matthew Krebs, Dr
Principal Investigator
The Christie Hospital

View source on ClinicalTrials.gov Contact study team (email)